Effects of individualized dialysate sodium prescription in hemodialysis – Results from a prospective interventional trial
Introduction: Individualized dialysate sodium prescription does affect weight gain, blood pressure (BP), and intradialytic complications. A prospective interventional trial (Dialysate Individualised Sodium (DISO) trial) was conducted to study this issue in Indian patients. Methods: Forty patients on...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Indian Journal of Nephrology |
Subjects: | |
Online Access: | http://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2020;volume=30;issue=1;spage=3;epage=7;aulast=Radhakrishnan |
id |
doaj-dac2705295144007a6eaf7a54838a984 |
---|---|
record_format |
Article |
spelling |
doaj-dac2705295144007a6eaf7a54838a9842020-11-25T01:30:24ZengWolters Kluwer Medknow PublicationsIndian Journal of Nephrology0971-40651998-36622020-01-013013710.4103/ijn.IJN_391_18Effects of individualized dialysate sodium prescription in hemodialysis – Results from a prospective interventional trialRadhika C RadhakrishnanSantosh VarugheseAbitha ChandranShibu JacobVinoi G DavidSuceena AlexanderAnjali MohapatraAnna T ValsonBasu GopalC PalaniArun JoseB AntonisamyV TamilarasiIntroduction: Individualized dialysate sodium prescription does affect weight gain, blood pressure (BP), and intradialytic complications. A prospective interventional trial (Dialysate Individualised Sodium (DISO) trial) was conducted to study this issue in Indian patients. Methods: Forty patients on thrice-weekly maintenance hemodialysis (HD) for at least 6 weeks were enrolled. The study was performed in two different phases. In the first phase, 12 consecutive HD sessions were done with a standard dialysate sodium concentration of 140 mEq/L. In the second phase, 12 consecutive HD sessions were done with dialysate sodium concentration set to individualized value (mean of pre-HD sodium concentration multiplied by Donnan coefficient of 0.95). Differences in pre- and post-HD sodium, interdialytic weight gain (IDWG), pre- and post-HD BP, thirst scores, and intradialytic adverse events during both phases were assessed. Results: The mean age of patients was 45.65 years (24 males, 16 females). The mean serum pre-HD sodium level was 138.7 ± 1.7 meq/L in the standard phase and 138.2 ± 2.6meq/L in the individualized phase (P = 0.229). In the standard phase, the mean IDWG was 2.64 ± 1.56 kg and 2.13 ± 0.99 kg in the individualized phase (P = 0.008). The mean pre-HD systolic BP was 138 ± 18 mmHg and 134 ± 17 mmHg in the standard and individualized phases (P = 0.008). There was no difference in intradialytic symptoms, hypotensive episodes or requirement of interventions. Hypertension episodes occurred at a mean value of 2.2 and 1.2 in the standard and individualized phases, respectively (P = 0.010). Conclusion: The use of individualized dialysate sodium level is safe and results in lower IDWG, pre-HD systolic BP, and intradialytic hypertension in patients on HD.http://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2020;volume=30;issue=1;spage=3;epage=7;aulast=Radhakrishnandialysate sodiumhemodialysisindividualized sodiumsodium set point |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Radhika C Radhakrishnan Santosh Varughese Abitha Chandran Shibu Jacob Vinoi G David Suceena Alexander Anjali Mohapatra Anna T Valson Basu Gopal C Palani Arun Jose B Antonisamy V Tamilarasi |
spellingShingle |
Radhika C Radhakrishnan Santosh Varughese Abitha Chandran Shibu Jacob Vinoi G David Suceena Alexander Anjali Mohapatra Anna T Valson Basu Gopal C Palani Arun Jose B Antonisamy V Tamilarasi Effects of individualized dialysate sodium prescription in hemodialysis – Results from a prospective interventional trial Indian Journal of Nephrology dialysate sodium hemodialysis individualized sodium sodium set point |
author_facet |
Radhika C Radhakrishnan Santosh Varughese Abitha Chandran Shibu Jacob Vinoi G David Suceena Alexander Anjali Mohapatra Anna T Valson Basu Gopal C Palani Arun Jose B Antonisamy V Tamilarasi |
author_sort |
Radhika C Radhakrishnan |
title |
Effects of individualized dialysate sodium prescription in hemodialysis – Results from a prospective interventional trial |
title_short |
Effects of individualized dialysate sodium prescription in hemodialysis – Results from a prospective interventional trial |
title_full |
Effects of individualized dialysate sodium prescription in hemodialysis – Results from a prospective interventional trial |
title_fullStr |
Effects of individualized dialysate sodium prescription in hemodialysis – Results from a prospective interventional trial |
title_full_unstemmed |
Effects of individualized dialysate sodium prescription in hemodialysis – Results from a prospective interventional trial |
title_sort |
effects of individualized dialysate sodium prescription in hemodialysis – results from a prospective interventional trial |
publisher |
Wolters Kluwer Medknow Publications |
series |
Indian Journal of Nephrology |
issn |
0971-4065 1998-3662 |
publishDate |
2020-01-01 |
description |
Introduction: Individualized dialysate sodium prescription does affect weight gain, blood pressure (BP), and intradialytic complications. A prospective interventional trial (Dialysate Individualised Sodium (DISO) trial) was conducted to study this issue in Indian patients. Methods: Forty patients on thrice-weekly maintenance hemodialysis (HD) for at least 6 weeks were enrolled. The study was performed in two different phases. In the first phase, 12 consecutive HD sessions were done with a standard dialysate sodium concentration of 140 mEq/L. In the second phase, 12 consecutive HD sessions were done with dialysate sodium concentration set to individualized value (mean of pre-HD sodium concentration multiplied by Donnan coefficient of 0.95). Differences in pre- and post-HD sodium, interdialytic weight gain (IDWG), pre- and post-HD BP, thirst scores, and intradialytic adverse events during both phases were assessed. Results: The mean age of patients was 45.65 years (24 males, 16 females). The mean serum pre-HD sodium level was 138.7 ± 1.7 meq/L in the standard phase and 138.2 ± 2.6meq/L in the individualized phase (P = 0.229). In the standard phase, the mean IDWG was 2.64 ± 1.56 kg and 2.13 ± 0.99 kg in the individualized phase (P = 0.008). The mean pre-HD systolic BP was 138 ± 18 mmHg and 134 ± 17 mmHg in the standard and individualized phases (P = 0.008). There was no difference in intradialytic symptoms, hypotensive episodes or requirement of interventions. Hypertension episodes occurred at a mean value of 2.2 and 1.2 in the standard and individualized phases, respectively (P = 0.010). Conclusion: The use of individualized dialysate sodium level is safe and results in lower IDWG, pre-HD systolic BP, and intradialytic hypertension in patients on HD. |
topic |
dialysate sodium hemodialysis individualized sodium sodium set point |
url |
http://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2020;volume=30;issue=1;spage=3;epage=7;aulast=Radhakrishnan |
work_keys_str_mv |
AT radhikacradhakrishnan effectsofindividualizeddialysatesodiumprescriptioninhemodialysisresultsfromaprospectiveinterventionaltrial AT santoshvarughese effectsofindividualizeddialysatesodiumprescriptioninhemodialysisresultsfromaprospectiveinterventionaltrial AT abithachandran effectsofindividualizeddialysatesodiumprescriptioninhemodialysisresultsfromaprospectiveinterventionaltrial AT shibujacob effectsofindividualizeddialysatesodiumprescriptioninhemodialysisresultsfromaprospectiveinterventionaltrial AT vinoigdavid effectsofindividualizeddialysatesodiumprescriptioninhemodialysisresultsfromaprospectiveinterventionaltrial AT suceenaalexander effectsofindividualizeddialysatesodiumprescriptioninhemodialysisresultsfromaprospectiveinterventionaltrial AT anjalimohapatra effectsofindividualizeddialysatesodiumprescriptioninhemodialysisresultsfromaprospectiveinterventionaltrial AT annatvalson effectsofindividualizeddialysatesodiumprescriptioninhemodialysisresultsfromaprospectiveinterventionaltrial AT basugopal effectsofindividualizeddialysatesodiumprescriptioninhemodialysisresultsfromaprospectiveinterventionaltrial AT cpalani effectsofindividualizeddialysatesodiumprescriptioninhemodialysisresultsfromaprospectiveinterventionaltrial AT arunjose effectsofindividualizeddialysatesodiumprescriptioninhemodialysisresultsfromaprospectiveinterventionaltrial AT bantonisamy effectsofindividualizeddialysatesodiumprescriptioninhemodialysisresultsfromaprospectiveinterventionaltrial AT vtamilarasi effectsofindividualizeddialysatesodiumprescriptioninhemodialysisresultsfromaprospectiveinterventionaltrial |
_version_ |
1725091574538305536 |